Infinity Pharmaceuticals Inc.
Filing:
425
Filed On:
02/23/23  5:26 PM  EST
Share Print
PDF PDF of All Exhibits
No Tables to Download
Compare
Exhibits
425
from 425 10 pages 425
02/23/23
EX-2.1
from 425 130 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Agreement and Plan of Merger Among Infinity Pharmaceuticals, Inc., Mei Pharma, Inc. and Meadow Merger Sub, Inc. Dated as of February 22, 2023
02/23/23
EX-3.1
from 425 1 page Amendment to Amended and Restated Bylaws of Infinity Pharmaceuticals, Inc., Effective February 22, 2023
02/23/23
EX-99.1
from 425 39 pages February 23, 2023 MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance 3 Promising Clinical Oncology Candidates
02/23/23
EX-99.2
from 425 7 pages MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
02/23/23
Graphics & Data Files
GRAPHIC
from 425 brhc10048558_ex99-1slide1.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide2.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide3.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide4.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide5.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide6.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide7.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide8.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide9.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide10.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide11.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide12.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide13.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide14.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide15.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide16.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide17.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide18.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide19.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide20.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide21.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide22.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide23.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide24.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide25.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide26.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide27.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide28.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide29.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide30.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide31.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide32.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide33.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide34.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide35.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide36.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide37.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide38.jpg
02/23/23
GRAPHIC
from 425 brhc10048558_ex99-1slide39.jpg
02/23/23
GRAPHIC
from 425 image00001.jpg
02/23/23
GRAPHIC
from 425 image00002.jpg
02/23/23
External Links